ArticleFrontiers in public health2026
Evaluation of diagnostic agreement between STANDARD E TB-Feron ELISA and TB-Feron FIA for tuberculosis infection in prison settings in Paraguay.
Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Accurate diagnosis of tuberculosis (TB) infection is essential for TB control, particularly in high-risk populations. Interferon-gamma release assays (IGRAs) are widely used for TB infection screening. This study assesses the diagnostic agreement between the STANDARD™ F TB-Feron fluorescence immunoassay (FIA) and the WHO-approved STANDARD E TB-Feron ELISA in penitentiary settings in Paraguay. Methods: A cross-sectional study was conducted among 737 participants (642 incarcerated individuals and 95 staff members). Both assays were performed on the same blood samples from each participant. Agreement was assessed using the Kappa coefficient, with stratified analyses across predefined risk groups: G1, no known TB exposure ( Results: Overall positivity was 57.7% with FIA and 56.9% with ELISA. Positivity rates for FIA/ELISA were: G1 (22.9%/22.9%), G2 (57.7%/58.4%), G3 (79.1%/79.1%), and G4 (71.6%/71.6%). Overall agreement was excellent (κ = 0.851; 95% CI: 0.812-0.889; Conclusion: The STANDARD F TB-Feron FIA demonstrated excellent concordance with ELISA, supporting its use as a reliable alternative for TB infection screening. In addition, the FIA offers key operational advantages, including reduced hands-on time (approximately 15 min compared with several hours for ELISA), the ability to process single samples without batch runs, and the use of portable equipment requiring less laboratory infrastructure, making it particularly suitable for decentralized and resource-limited settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.